CO-PROMOTION AGREEMENT by and among AMARIN PHARMACEUTICALS IRELAND LIMITED, AMARIN PHARMA, INC. and KOWA PHARMACEUTICALS AMERICA, INC. MARCH 31, 2014Co-Promotion Agreement • May 9th, 2014 • Amarin Corp Plc\uk • Pharmaceutical preparations • New York
This Co-Promotion Agreement (this “Agreement”) is entered into as of March 31, 2014 (the “Effective Date”) by and among Amarin Pharmaceuticals Ireland Limited, a company incorporated under the laws of Ireland (registered number 408912) with offices at 2 Pembroke House Upper Pembroke Street 28-32, Dublin 2, Ireland (“Amarin Ireland”), and Amarin Pharma, Inc., a Delaware corporation with offices at 1430 Route 206 North, Suite 101, Bedminster, NJ 07921 (“Amarin Pharma”, and collectively with Amarin Ireland, “Amarin”), on the one hand, and Kowa Pharmaceuticals America, Inc., a Delaware corporation with offices at 530 Industrial Park Blvd, Montgomery, AL 36117 (“Kowa”), on the other hand.
